Hi, everyone!

This is my first question posted to Research Gate, so I hope I’m doing this right. Please correct me if I need to change anything in future posts.

I’ve attempted performing a viral plaque assay three times now without any plaques forming in any of the trials. I have little to no background in microbiology, so it’s possible that I’m making a simple and obvious mistake, but I’m open to any and all feedback. I am using the mammalian cell NCTC clone 1469 in a 6-well plate and infecting it with MHV. I’ve outlined the general procedure used below.

  • Begin growing NCTC clone 1469 cells in 6-well plates. DMEM with 10% horse serum is used as growing media, and cells are left to grow for ~24 hours.
  • Prepare virus dilutions by placing ~1 mL of undiluted virus solution (of unknown concentration) in 1 vial. Take 500 μL from the first vial and place in a second vial, adding 500 μL of NCTC 135. Repeat the same dilution process four more times to obtain dilutions of 10-1 to 10-5.
  • Remove growing media from the prepared 6-well plate and rinse with PBS.
  • Add 500 μL of each viral dilution to a separate well.
  • Incubate the infected monolayers at 37oC for 1 hour, shaking plates occasionally to distribute viral dilutions in wells.
  • Overlay inoculated cells with 2 mL of NCTC 135 containing 1% bacto agar, 5% horse serum, and 10% tryptose phosphate broth.
  • Incubate well plate at 37oC for ~24 hours, or until plaques become visible.
  • Discard the agarose layer and stain the culture with a solution of 0.1% crystal violet and 20% ethanol for 10 minutes to 1 hour.
  • Count plaques in each well and calculate the concentration of initial suspension in PFU/mL.
  • Is it possible that an Endpoint Dilution Assay would be more effective in determining viral concentration for this specific cell and virus combination?

    Thank you!

    More Rochelle Plaizier's questions See All
    Similar questions and discussions